Group One Trading, L.P. Takeda Pharmaceutical CO LTD Transaction History

Group One Trading, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$15.57 - $17.11 $170,693 - $187,576	-10,963 Reduced 68.79%	4,975 $78,000
Q1 2023 May 12, 2023	BUY	$15.28 - $16.48 $243,532 - $262,658	15,938 New	15,938 $262,000
Q3 2022 Nov 09, 2022	SELL	$12.8 - $28.65 $452,428 - $1.01 Million	-35,346 Reduced 65.78%	18,386 $238,000
Q2 2022 Aug 11, 2022	BUY	$13.12 - $15.03 $412,007 - $471,987	31,403 Added 140.64%	53,732 $754,000
Q1 2022 May 12, 2022	BUY	$13.54 - $15.35 $302,334 - $342,750	22,329 New	22,329 $320,000
Q1 2021 May 12, 2021	SELL	$16.71 - $19.9 $655,483 - $780,617	-39,227 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$15.39 - $18.97 $603,703 - $744,136	39,227 New	39,227 $714,000
Q2 2019 Aug 09, 2019	SELL	$16.58 - $20.49 $318,369 - $393,448	-19,202 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$16.7 - $21.52 $320,673 - $413,227	19,202 New	19,202 $391,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.